Journal article
BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells
- Abstract:
-
Bromodomain-containing protein 4 (BRD4) is a member of the bromo- and extraterminal (BET) domain-containing family of epigenetic readers which is under intensive investigation as a target for anti-tumor therapy. BRD4 plays a central role in promoting the expression of select subsets of genes including many driven by oncogenic transcription factors and signaling pathways. However, the role of BRD4 and the effects of BET inhibitors in non-transformed cells remain mostly unclear. We demonstrate ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
German Academic Exchange Service
More from this funder
Erasmus Mundus External Cooperation Window
More from this funder
Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences
More from this funder
Cancer Prevention Research Institute of Texas
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Nucleic Acids Research Journal website
- Volume:
- 45
- Issue:
- 6
- Pages:
- 3130-3145
- Publication date:
- 2016-12-15
- Acceptance date:
- 2016-12-09
- DOI:
- EISSN:
-
1362-4962
- ISSN:
-
0305-1048
- Pmid:
-
27980063
- Source identifiers:
-
666490
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:666490
- UUID:
-
uuid:1f5ce371-7643-4cd2-a466-5d39bac395de
- Local pid:
- pubs:666490
- Deposit date:
- 2018-07-13
Terms of use
- Copyright holder:
- Knapp et al
- Copyright date:
- 2016
- Notes:
- © The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record